PROCALCITONIN IS A MARKER OF NON-COMMUNICABLE DISEASES IN PREMATURE CHILDREN

FULL TEXT:

Abstract

This review presents information on the results of a scientific work devoted to the study of procalcitonin in premature babies. It has been established that non-infectious factors may also be the reason for the increase in the level of procalcitonin in premature newborns. Therefore, for the diagnosis of sepsis, the threshold values ​​for the concentration of procalcitonin in the first few days of life differ from the generally accepted reference values. An increase in the concentration of procalcitonin in the blood plasma was determined in the first few days of life and under normal physiological conditions. The dynamics of the decrease in the concentration of procalcitonin in premature infants is significantly slower than in full-term ones. It has been proven that an increase in the level of procalcitonin affects not only an infectious factor, but also non-infectious causes: respiratory distress syndrome, transient tachypnea of ​​newborns, pneumothorax, congenital diaphragmatic hernia, hemodynamic insufficiency, asphyxia at birth and the need for resuscitation. It is recommended that procalcitonin values ​​should not be interpreted in isolation, but in combination with clinical data.

About the Authors

List of references

Бахранова Н.Р., & Юлдашева Г.Г.(2021). Патогенетические Аспекты Коронавирусной Инфекции У Беременных. Central asian journal of medical and natural sciences, 64-69. https://doi.org/10.47494/cajmns.vi0.351

Е.С. Чурсина, Г.М. Дементьева Прокальцитонин и его значение как маркера тяжелых бактериальных инфекций у новорожденных детей Российский вестник перинатологии и педиатрии, 6, 2007 https://cyberleninka.ru/article/n/prokaltsitonin-i-ego-znachenie-kak-markera-tyazhelyh-bakterialnyh-infektsiy-u-novorozhdennyh-detey/viewer

Л.Д.Танцюра. Прокальцитонин у новорожденных детей. Неоднозначность оценки. Современная педиатрия 5(93)/2018 37 https://med-expert.com.ua/journals/prokalcitonin-u-novorozhdennyh-detej-neodnoznachnost-ocenki/ DOI: https://doi.org/10.15574/SP.2018.93.37

Hans_Gerhard Schneider, Que Thanh Lam. (2007). Procalcitonin for the clinical laboratory: a review. Pathology. 39(4): 383—390 https://pubmed.ncbi.nlm.nih.gov/17676478/ DOI: https://doi.org/10.1080/00313020701444564

Jacobs J., Lund P., Potts J. et al. Procalcitonin is a glycoprotein. J Biol Chem 2018; 256: 2803—2807. https://pubmed.ncbi.nlm.nih.gov/7204375/ DOI: https://doi.org/10.1016/S0021-9258(19)69685-7

Le Moullec J., Jullienne A., Chenais J. et al. The complete sequence of preprocalcitonin. FEBS Lett 1984; 167: 93—97 https://pubmed.ncbi.nlm.nih.gov/6546550/ DOI: https://doi.org/10.1016/0014-5793(84)80839-X

Yuldasheva Gulnoz Giyasovna, Bakhranova Nasiba Ramazanovna, & Baratov Sunnat Samiyevich. (2021). Statistical analysis of the structure of the birth rate of underweight children in the bukhara region. Art of Medicine International Medical Scientific Journal, Volume-1(Issue-2), 73–81. https://doi.org/10.5281/zenodo.5155178

How to Cite

Rustamov Б. . (2022). PROCALCITONIN IS A MARKER OF NON-COMMUNICABLE DISEASES IN PREMATURE CHILDREN. International Journal of Scientific Pediatrics, 1(6), 05–08. https://doi.org/10.56121/2181-2926-2022-6-05-08
Views: 134

Most read articles by the same author(s)